Milestone Scientific (NYSE:MLSS) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued to investors on Wednesday. The brokerage set a “hold” rating on the stock.

Separately, Benchmark reiterated a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Price Performance

MLSS stock opened at $1.29 on Wednesday. The company has a market capitalization of $100.48 million, a price-to-earnings ratio of -18.43 and a beta of 1.10. Milestone Scientific has a 1-year low of $0.54 and a 1-year high of $1.39. The business has a 50 day simple moving average of $0.97 and a two-hundred day simple moving average of $0.93.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of MLSS. Y Intercept Hong Kong Ltd purchased a new position in shares of Milestone Scientific in the 3rd quarter worth approximately $48,000. World Investment Advisors LLC bought a new stake in Milestone Scientific in the third quarter worth $91,000. Carnegie Investment Counsel boosted its stake in Milestone Scientific by 18.9% during the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after buying an additional 27,412 shares during the period. Finally, Geode Capital Management LLC increased its position in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after acquiring an additional 31,572 shares during the last quarter. 5.79% of the stock is owned by hedge funds and other institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.